FES-PET guides second-line therapy decisions in breast cancer
FES-PET guides second-line therapy decisions in breast cancer AuntMinnie
🎗️
Онкология
🎗️Лента новостей
Онкология
FDA approves combo therapy for breast cancer
The FDA approved combination imlunestrant plus abemaciclib for adults with hormone therapy-resistant estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. The combination therapy (Inluriyo and Verzenio, Eli Lilly & Co.) was approved with the indication for certain patients with…
/https%3A%2F%2Fs3.eu-central-1.amazonaws.com%2Fmedia.my.ua%2Ffeed%2F46%2F54163b142c1b308d6079b44bcba60353.jpg)
Онкология
Что поможет снизить риск рецидива рака и смерти: исследователи ошеломили открытием
Что поможет снизить риск рецидива рака и смерти: исследователи ошеломили открытием my.ua
Онкология
Richard Sassun Shares New Research on Recurrent Ovarian Cancer Treatment
Richard Sassun Shares New Research on Recurrent Ovarian Cancer Treatment Oncodaily
Онкология
Variety of Yale Cancer Center Research Highlights to be Presented at Radiation and Oncology Conference
Variety of Yale Cancer Center Research Highlights to be Presented at Radiation and Oncology Conference Yale School of Medicine
🎗️
Онкология
Stage 3 Lung Cancer Injection Before Radiation: What Patients Need to Know
Stage 3 Lung Cancer Injection Before Radiation: What Patients Need to Know Cure Today
Онкология
Lights of Hope honors cancer community while pushing Congress for more research dollars
Lights of Hope honors cancer community while pushing Congress for more research dollars WJLA
Онкология
U.S. FDA approves Inluriyo in combination with Verzenio for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
U.S. FDA approves Inluriyo in combination with Verzenio for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer Investing News Network
Онкология
A single protein may help aggressive breast cancer spread to the brain and evade immune defenses
Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast cancer spread to the brain and escape the body's immune defenses.
Онкология
ВПЧ-18 не означает рак, но требует обследования — Новости Нижнего Новгорода и области
ВПЧ-18 не означает рак, но требует обследования — Новости Нижнего Новгорода и области Бизнес News
Онкология
Врачи списывали симптомы на простуду, пока у ребенка развивался рак
Врачи списывали симптомы на простуду, пока у ребенка развивался рак Новости Zakon.kz
🎗️
Онкология
Closing Racial and Geographic Gaps in Blood Cancer Care
Closing Racial and Geographic Gaps in Blood Cancer Care Targeted Oncology
Онкология
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool
Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.